Sarah Opie-Martin (Sarah Martin)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Amyotrophic Lateral Sclerosis

Palliative Care

Cross Sectional

Top Venues

Amyotrophic lateral sclerosis & frontotemporal degeneration

Genome medicine

Journal of neurology, neurosurgery, and psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Shojaie, Ahmad Al Khleifat, Sarah Garrahy, Haniah Habash-Bailey, Rachel Thomson, Sarah Opie-Martin, Sara Javidnia, P Nigel Leigh, Ammar Al Chalabi
Investigating the impact of socioeconomic status on amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration (2024)
Ali Shojaie, Ahmad Al Khleifat, Sarah Opie-Martin, Payam Sarraf, Ammar Al Chalabi
Non-motor symptoms in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Thomas P Spargo, Sarah Opie-Martin, Guy P Hunt, Munishikha Kalia, Ahmad Al Khleifat, Simon D Topp, Christopher E Shaw, Ammar Al-Chalabi, Alfredo Iacoangeli, null null
SOD1-ALS-Browser: a web-utility for investigating the clinical phenotype in SOD1 amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Allison Ann Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, Jennifer Fifita, Lyndal Henden, Ingrid M Keseler, Steven Lenz, Heather Marriott, Emily Mccann, Maysen Mesaros, Sarah Opie-Martin, Emma Owens, Brooke Palus, Justyne Ross, Zhanjun Wang, Hannah White, Ammar Al Chalabi, Peter M Andersen, Michael Benatar, Ian Blair, Johnathan Cooper-Knock, Elizabeth A Harrington, Jeannine Heckmann, John Landers, Cristiane Moreno, Melissa Nel, Evadnie Rampersaud, Jennifer Roggenbuck, Guy Rouleau, Bryan Traynor, Marka Van Blitterswijk, Wouter Van Rheenen, Jan Veldink, Jochen Weishaupt, Luke Drury, Matthew B Harms, Sali M K Farhan, null null
Clinical testing panels for ALS: global distribution, consistency, and challenges. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Allison Ann Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, Jennifer Fifita, Lyndal Henden, Ingrid M Keseler, Steven Lenz, Heather Marriott, Emily Mccann, Maysen Mesaros, Sarah Opie-Martin, Emma Owens, Brooke Palus, Justyne Ross, Zhanjun Wang, Hannah White, Ammar Al Chalabi, Peter M Andersen, Michael Benatar, Ian Blair, Johnathan Cooper-Knock, Elizabeth A Harrington, Jeannine Heckmann, John Landers, Cristiane Moreno, Melissa Nel, Evadnie Rampersaud, Jennifer Roggenbuck, Guy Rouleau, Bryan Traynor, Marka Van Blitterswijk, Wouter Van Rheenen, Jan Veldink, Jochen Weishaupt, Luke Drury, Matthew B Harms, Sali M K Farhan, null null
Clinical testing panels for ALS: global distribution, consistency, and challenges. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Thomas P Spargo, Sarah Opie-Martin, Harry Bowles, Cathryn M Lewis, Alfredo Iacoangeli, Ammar Al Chalabi
Calculating variant penetrance from family history of disease and average family size in population-scale data. Genome medicine 14 (1) (2022)
Lucy S Musson, Alexis Collins, Sarah Opie-Martin, Andrea Bredin, Esther V Hobson, Emily Barkhouse, Mark C Coulson, Theocharis Stavroulakis, Rebecca L Gould, Ammar Al Chalabi, Christopher J McDermott
Impact of the covid-19 pandemic on amyotrophic lateral sclerosis care in the UK. Amyotrophic lateral sclerosis & frontotemporal degeneration (2022)
Thomas P Spargo, Sarah Opie-Martin, Harry Bowles, Cathryn M Lewis, Alfredo Iacoangeli, Ammar Al Chalabi
Calculating variant penetrance from family history of disease and average family size in population-scale data. Genome medicine 14 (1) (2022)
Thomas P Spargo, Sarah Opie-Martin, Harry Bowles, Cathryn M Lewis, Alfredo Iacoangeli, Ammar Al Chalabi
Calculating variant penetrance from family history of disease and average family size in population-scale data. Genome medicine 14 (1) (2022)
Thomas P Spargo, Sarah Opie-Martin, Harry Bowles, Cathryn M Lewis, Alfredo Iacoangeli, Ammar Al Chalabi
Calculating variant penetrance from family history of disease and average family size in population-scale data. Genome medicine 14 (1) (2022)
Thomas P Spargo, Sarah Opie-Martin, Harry Bowles, Cathryn M Lewis, Alfredo Iacoangeli, Ammar Al Chalabi
Calculating variant penetrance from family history of disease and average family size in population-scale data. Genome medicine 14 (1) (2022)
Sarah Opie-Martin, Lynn Ossher, Andrea Bredin, Anna Kulka, Neil Pearce, Kevin Talbot, Ammar Al Chalabi
Motor Neuron Disease Register for England, Wales and Northern Ireland-an analysis of incidence in England. Amyotrophic lateral sclerosis & frontotemporal degeneration 22 (1-2) (2020)
Sarah Opie-Martin, Robyn E Wootton, Ashley Budu-Aggrey, Aleksey Shatunov, Ashley R Jones, Alfredo Iacoangeli, Ahmad Al Khleifat, George Davey-Smith, Ammar Al Chalabi
Relationship between smoking and ALS: Mendelian randomisation interrogation of causality. Journal of neurology, neurosurgery, and psychiatry 91 (12) (2020)
Sarah Opie-Martin, Ahmad Al Khleifat, Ammar Al-Chalabi
What causes amyotrophic lateral sclerosis? F1000Research 6 (2017)
Sarah Opie-Martin, Emma Trevor-Jones, Sabyha Khan, Keelan Shaw, Deepti Marchment, Anna Kulka, Catherine E Ellis, Rachel Burman, Matthew C Kiernan, Liam Carroll, Leah Mursaleen, P Nigel Leigh, Christopher E Shaw, Neil Pearce, Daniel Stahl, Ammar Al Chalabi
The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison. Amyotrophic lateral sclerosis & frontotemporal degeneration 18 (7-8) (2017)